The US Federal Drug Administration’s equivocal verdict on Sanofi-Aventis’s potential blockbuster drug Acomplia is a blow. FDA’s reservations are announced on 17 February. And if the prove relatively minor, Sanofi faces extra short-term...
More than 2 years with Instablogs, it has provided me with a global platform to ventilate my knowledge and views on environmental and health issues. Previous to this, I have been reporting health as a ‘Television Journalist’ for 3 years. Two years of ‘Teaching Journalism’ in undergraduate colleges have given me insight to what helped me as a professional.
Working with an NGO as a ‘Science and...